Sesamol Alleviates Manganese-Induced Neuroinflammation and Cognitive Impairment Via Regulating the Microglial cGAS-STING/NF-kB Pathway

Jinxia Wu,Tingting Guo,Honggang Chen,Ming Li,Changhao Yang,Peng Su,Jing-Yuan Chen,Wenjing Luo
DOI: https://doi.org/10.2139/ssrn.4249940
2022-01-01
SSRN Electronic Journal
Abstract:Inflammatory responses mediated by microglia are essential contributors to the pathogenesis of manganese (Mn)-induced neurotoxicity, which results in neurodegeneration and cognitive dysfunction. Inhibition of microglia-mediated inflammation has been shown to alleviate Mn-induced neurotoxicity. Sesamol, derived from sesame, has neuroprotective properties in various disease models, including neurological diseases. Whether sesamol protects against Mn-induced neurological injuries has yet to be determined. Here, both in vivo and in vitro Mn exposure models were established to address the beneficial effects of sesamol on Mn-induced neurotoxicity. We showed that administration of sesamol mitigated learning and memory deficits in Mn-treated mice. Furthermore, sesamol reduced Mn-induced microglial activation and expression of proinflammatory mediators (TNF-α, iNOS, and Cxcl10), while exerting a marginal effect on anti-inflammation and microglial phagocytosis. Mn exposure activated the microglial cGAS-STING pathway and sesamol inhibited this pathway by reducing the phosphorylation of STING and NF-κB, concomitantly decreasing IFN-α and IFN-β synthesis. In summary, our novel results indicated that sesamol exerted its protective effects on Mn-induced neuroinflammation and cognitive impairment via the microglial cGAS-STING / NF-κB pathway, providing evidence that sesamol may serve as an effective therapeutic for preventing and treating Mn-induced neurotoxicity.
What problem does this paper attempt to address?